These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 33010678)
1. Generation of induced pluripotent stem cells (NIMHi002-A and NIMHi003-A) from two sporadic Parkinson's disease patient of East Indian ethnicity. Datta I; Jagtap S; Sowmithra ; Yadav R; Pal PK Stem Cell Res; 2020 Dec; 49():101995. PubMed ID: 33010678 [TBL] [Abstract][Full Text] [Related]
2. Generation of induced pluripotent stem cells (NIMHi001-A) from a Parkinson's disease patient of East Indian ethnicity carrying LRRK2 I1371V variant. Datta I; Sowmithra ; Jagtap S; Potdar C; Yadav R; Pal P Stem Cell Res; 2020 Apr; 44():101768. PubMed ID: 32244201 [TBL] [Abstract][Full Text] [Related]
3. Generation of induced pluripotent stem cells (NIMHi015-A) from a Parkinson's Disease patient harbouring a homozygous Exon 3 deletion in the PRKN gene. Banerjee R; Ghanty R; Jagtap S; Holla V; Kamble N; Yadav R; Pal PK; Datta I Stem Cell Res; 2024 Jun; 77():103440. PubMed ID: 38739971 [TBL] [Abstract][Full Text] [Related]
4. Generation of induced pluripotent stem cells (NIMHi004-A, NIMHi005-A and NIMHi006-A) from healthy individuals of Indian ethnicity with no mutation for Parkinson's disease related genes. Jagtap S; Sowmithra ; Yadav R; Pal PK; Datta I Stem Cell Res; 2022 Apr; 60():102716. PubMed ID: 35220026 [TBL] [Abstract][Full Text] [Related]
5. Generation of an induced pluripotent stem cell line (KNIHi001-A) by reprogramming peripheral blood mononuclear cells isolated from a patient with Parkinson's disease. Baek D; Lee KG; Sohn HY; Park JH; Lee HK; Bayarsaikhan G; Yoo SW; Lee B; Kim JS; Koh YH; Kwon M Stem Cell Res; 2024 Apr; 76():103358. PubMed ID: 38447455 [TBL] [Abstract][Full Text] [Related]
7. Generation of two iPSC lines, (ICGi015-A and ICGi015-B), by reprogramming peripheral blood mononuclear cells from a patient with Parkinson's disease. Sharipova DV; Kovalenko VR; Bairamova EM; Vartanova VA; Grigor'eva EV; Vyatkin YV; Khabarova EA; Rzaev DA; Zakian SM; Medvedev SP Stem Cell Res; 2019 Dec; 41():101652. PubMed ID: 31733442 [TBL] [Abstract][Full Text] [Related]
8. Derivation of human induced pluripotent stem cell (iPSC) line from a 79year old sporadic male Parkinson's disease patient. Zhang S; Liu L; Hu Y; Lv Z; Li Q; Gong W; Sha H; Wu H Stem Cell Res; 2017 Mar; 19():43-45. PubMed ID: 28413004 [TBL] [Abstract][Full Text] [Related]
9. Generation of an iPSC line from a 79-year-old female patient diagnosed with sporadic Parkinson's disease. Liu J; Du J; Ma X; Jin Y; Yang Q; Zhai Y; Cheng J; Luan F; Ma M; Zhang Z; Ren Q; Cui H Stem Cell Res; 2024 Aug; 78():103450. PubMed ID: 38820865 [TBL] [Abstract][Full Text] [Related]
10. Generation of 2 induced pluripotent stem cell lines derived from patients with Parkinson's disease carrying LRRK2 G2385R variant. Cheng YC; Huang CY; Ho MC; Hsu YH; Syu SH; Lu HE; Lin HI; Lin CH; Hsieh PCH Stem Cell Res; 2018 Apr; 28():1-5. PubMed ID: 29414410 [TBL] [Abstract][Full Text] [Related]
11. Generation of induced pluripotent stem cells (IBMSi011-A) from a patient with Parkinson's disease carrying LRRK2 p.I1371V mutation. Lin HI; Cheng YC; Ko HW; Wen CH; Lu HE; Huang CY; Hsieh PCH; Lin CH Stem Cell Res; 2019 May; 37():101447. PubMed ID: 31029016 [TBL] [Abstract][Full Text] [Related]
12. Generation of induced pluripotent stem cells from a patient with Parkinson's disease carrying LRRK2 p.I2012T mutation. Lin CH; Cheng YC; Lin HI; Ho MC; Hsu YH; Wen CH; Ko HW; Lu HE; Huang CY; Hsieh PCH Stem Cell Res; 2017 Dec; 25():123-127. PubMed ID: 29127874 [TBL] [Abstract][Full Text] [Related]
13. Reprogramming of a human induced pluripotent stem cell (iPSC) line (IBMSi012-A) from an early-onset Parkinson's disease patient harboring a homozygous p.D331Y mutation in the PLA2G6 gene. Cheng YC; Lin HI; Syu SH; Lu HE; Huang CY; Lin CH; Hsieh PCH Stem Cell Res; 2019 May; 37():101432. PubMed ID: 30978640 [TBL] [Abstract][Full Text] [Related]
14. Efficient Generation of Non-Integration and Feeder-Free Induced Pluripotent Stem Cells from Human Peripheral Blood Cells by Sendai Virus. Ye H; Wang Q Cell Physiol Biochem; 2018; 50(4):1318-1331. PubMed ID: 30355953 [TBL] [Abstract][Full Text] [Related]
15. Generation of induced pluripotent stem cell line (ZZUi007-A) from a 52-year-old patient with a novel CHCHD2 gene mutation in Parkinson's disease. Wang Y; Wang Z; Sun H; Mao C; Yang J; Liu Y; Liu H; Zhang S; Zhang J; Xu Y; Shi C Stem Cell Res; 2018 Oct; 32():87-90. PubMed ID: 30237140 [TBL] [Abstract][Full Text] [Related]
16. Derivation of human induced pluripotent stem cell (iPSC) line with LRRK2 gene R1398H variant in Parkinson's disease. Ma D; Tio M; Ng SH; Li Zeng ; Lim CY; Zhao Y; Tan EK Stem Cell Res; 2017 Jan; 18():48-50. PubMed ID: 28395803 [TBL] [Abstract][Full Text] [Related]
17. Generation of two control iPSC clones NCCSi008-A and NCCSi008-B from an individual of Indian ethnicity. Vaidyanath A; Khan M; Shiras A Stem Cell Res; 2020 May; 45():101765. PubMed ID: 32315960 [TBL] [Abstract][Full Text] [Related]
18. Generation of an induced pluripotent stem cell line, FJMUUHi001-A, from a hereditary Parkinson's disease patient with homozygous mutation of c.189dupA in PARK7. Chen ZT; Zhao ZH; Chen LN; Fan F; Cai GE; Weng HD; Wang YQ; Liao LM; Chen XC; Huang E; Ye QY Stem Cell Res; 2021 Mar; 51():102175. PubMed ID: 33485186 [TBL] [Abstract][Full Text] [Related]
19. Reprogramming of a human induced pluripotent stem cell (iPSC) line from a Parkinson's disease patient with a R1628P variant in the LRRK2 gene. Ma D; Zhou W; Ng EY; Zeng L; Zhao Y; Tan EK Stem Cell Res; 2017 Jan; 18():45-47. PubMed ID: 28395802 [TBL] [Abstract][Full Text] [Related]
20. Generation of a human induced pluripotent stem cell (iPSC) line carrying the Parkinson's disease linked LRRK2 variant S1647T. Ma D; Ng SH; Zeng L; Zhao Y; Tan EK Stem Cell Res; 2017 Jan; 18():54-56. PubMed ID: 28395805 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]